智通财经APP获悉,周五,GlucoTrack(GCTK.US)飙升超123%,报10.91美元。消息面上,GlucoTrack于2025年9月11日宣布与第六区资本达成协议,出售最高2000万美元普通股。GlucoTrack主营业务为开发植入式连续血糖监测设备,该设备直接测量血液血糖,消除滞后时间,适用于糖尿病患者。

本文地址: http://www.jiaotongmi.com/article/2175.html
文章来源:admin
版权声明:除非特别标注,否则均为本站原创文章,转载时请以链接形式注明文章出处。
2025-11-11admin
2025-11-10admin
2025-11-09admin
2025-11-08admin
2025-11-07admin
2025-11-06admin
2025-11-05admin
2025-11-04admin
2025-11-03admin
2025-10-29admin
2025-09-08admin
2025-09-08admin
2025-09-13admin
2025-09-17admin
2025-09-17admin
2025-09-08admin
2025-09-09admin
2025-09-09admin
2025-09-13admin
2025-09-11admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
扫码二维码
获取最新动态
